135 related articles for article (PubMed ID: 7513092)
1. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
Hohlfeld T; Scharnowski F; Braun M; Schrör K
Thromb Haemost; 1994 Jan; 71(1):112-8. PubMed ID: 7513092
[TBL] [Abstract][Full Text] [Related]
2. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits.
Hwang SY; Son DJ; Kim IW; Kim DM; Sohn SH; Lee JJ; Kim SK
Phytother Res; 2008 Jun; 22(6):778-83. PubMed ID: 18446850
[TBL] [Abstract][Full Text] [Related]
3. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
[TBL] [Abstract][Full Text] [Related]
4. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
Kosugi T; Nakamura M; Saitoh S; Kinjoh K
Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum cholesterol and thromboxane B2 levels and atherosclerotic lesions in rabbits fed a high cholesterol diet.
Restori G; Boiardi L; Manarini S; Cerletti C; Gelmini G; Barbagallo M; Novo S; Passeri M; Strano A
Int Angiol; 1990; 9(4):256-8. PubMed ID: 2099958
[TBL] [Abstract][Full Text] [Related]
6. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
Cattaneo M; Akkawat B; Lecchi A; Cimminiello C; Capitanio AM; Mannucci PM
Thromb Haemost; 1991 Dec; 66(6):694-9. PubMed ID: 1665598
[TBL] [Abstract][Full Text] [Related]
7. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits.
Weber AA; Hohlfeld T; Strobach H; Schrör K
J Cardiovasc Pharmacol; 1993 Feb; 21(2):332-8. PubMed ID: 7679170
[TBL] [Abstract][Full Text] [Related]
8. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
Honey AC; Lad N; Tuffin DP
Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692
[TBL] [Abstract][Full Text] [Related]
9. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
10. ADP plays a key role in thrombogenesis in rats.
Maffrand JP; Bernat A; Delebassée D; Defreyn G; Cazenave JP; Gordon JL
Thromb Haemost; 1988 Apr; 59(2):225-30. PubMed ID: 3133809
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of ticlopidine: relation between dose and time of administration to platelet inhibition.
Kuzniar J; Splawinska B; Malinga K; Mazurek AP; Splawinski J
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):357-61. PubMed ID: 8864800
[TBL] [Abstract][Full Text] [Related]
13. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
14. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
Wang J; Albertson CM; Zheng H; Fink LM; Herbert JM; Hauer-Jensen M
Thromb Haemost; 2002 Jan; 87(1):122-8. PubMed ID: 11848440
[TBL] [Abstract][Full Text] [Related]
15. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
18. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
19. ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbits.
Weber A; Hohlfeld T; Schrör K
Thromb Res; 1991 Dec; 64(6):703-12. PubMed ID: 1798959
[TBL] [Abstract][Full Text] [Related]
20. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
